Pathogenesis of protein energy wasting in chronic kidney disease and its prevention strategy

LI Xiaodong; ZHOU Ping

doi:10.7619/jcmp.20210465

Journal of Clinical Medicine in Practice > 2021 > 25(7): 118-122. > DOI: 10.7619/jcmp.20210465

LI Xiaodong, ZHOU Ping. Pathogenesis of protein energy wasting in chronic kidney disease and its prevention strategy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 118-122. DOI: 10.7619/jcmp.20210465

Citation:

PDF (687 KB)

Pathogenesis of protein energy wasting in chronic kidney disease and its prevention strategy

LI Xiaodong¹,
ZHOU Ping^2, ,

1.
Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086
2.
Department of Pediatrics, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086

More Information

Received Date: January 24, 2021
Available Online: April 20, 2021
Published Date: April 14, 2021

Graphical Abstract

Abstract

Abstract

Among the numerous complications of chronic kidney disease (CKD), the prevalence of protein energy wasting (PEW) is high, and it can occur in all stages of CKD. PEW significantly affects the quality of life of patients with CKD and is strongly associated with poor outcomes. Therefore, early diagnosis and timely intervention of PEW are of great significance for the prognosis of patients with CKD. In this paper, the research progress on CKD complicated with PEW in recent years is reviewed from the aspects of etiology, pathogenesis and prevention and treatment strategies of PEW.
- chronic kidney disease,
- protein energy wasting,
- prevention and treatment,
- malnutrition

FullText(HTML)

References (45)

References

[1]	Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019(GBD 2019) Results[DB/OL]. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2020. Available from http://ghdx.healthdata.org/gbd-results-tool.
[2]	GBD Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222. doi: 10.1016/S0140-6736(20)30925-9
[3]	CARRERO J J, THOMAS F, NAGY K, et al. Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the international society of renal nutrition and metabolism[J]. J Ren Nutr, 2018, 28(6): 380-392. doi: 10.1053/j.jrn.2018.08.006
[4]	KOPPE L, FOUQUE D, KALANTAR-ZADEH K. Kidney Cachexia or protein-energy wasting in chronic kidney disease: facts and numbers[J]. J Cachexia Sarcopenia Muscle, 2019, 10(3): 479-484. doi: 10.1002/jcsm.12421
[5]	FOUQUE D, KALANTAR-ZADEH K, KOPPLE J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease[J]. Kidney Int, 2008, 73(4): 391-398. doi: 10.1038/sj.ki.5002585
[6]	OKAMOTO T, HATAKEYAMA S, KODAMA H, et al. The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis[J]. BMC Nephrol, 2018, 19(1): 71. doi: 10.1186/s12882-018-0872-y
[7]	REZEQ H A, KHDAIR L N, HAMDAN Z I, et al. Prevalence of malnutrition in hemodialysis patients: a single-center study in Palestine[J]. Saudi J Kidney Dis Transpl, 2018, 29(2): 332-340. doi: 10.4103/1319-2442.229264
[8]	IOREMBER F M. Malnutrition in chronic kidney disease[J]. Front Pediatr, 2018, 6: 161. doi: 10.3389/fped.2018.00161
[9]	REES L, JONES H. Nutritional management and growth in children with chronic kidney disease[J]. Pediatr Nephrol, 2013, 28(4): 527-536. doi: 10.1007/s00467-012-2258-x
[10]	BI X, CHU M Z, AI H L, et al. Association of serum IL-18 with protein-energy wasting in end-stage renal disease patients on haemodialysis[J]. Int Urol Nephrol, 2019, 51(7): 1271-1278. doi: 10.1007/s11255-019-02167-5
[11]	SNAEDAL S, QURESHI A R, LUND S H, et al. Dialysis modality and nutritional status are associated with variability of inflammatory markers[J]. Nephrol Dial Transplant, 2016, 31(8): 1320-1327. doi: 10.1093/ndt/gfw104
[12]	LEE B T, AHMED F A, HAMM L L, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease[J]. BMC Nephrol, 2015, 16: 77. doi: 10.1186/s12882-015-0068-7
[13]	HYUN Y Y, LEE K B, HAN S H, et al. Nutritional status in adults with predialysis chronic kidney disease: KNOW-CKD study[J]. J Korean Med Sci, 2017, 32(2): 257-263. doi: 10.3346/jkms.2017.32.2.257
[14]	KRAUT J A, MADIAS N E. Adverse effects of the metabolic acidosis of chronic kidney disease[J]. Adv Chronic Kidney Dis, 2017, 24(5): 289-297. doi: 10.1053/j.ackd.2017.06.005
[15]	苗文艳, 刘健. 胰岛素样生长因子1与慢性肾脏病患者蛋白质能量消耗的关系[J]. 中华肾脏病杂志, 2019, 35(9): 717-720. doi: 10.3760/cma.j.issn.1001-7097.2019.09.014
[16]	GARIBOTTO G, SOFIA A, SAFFIOTI S, et al. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease[J]. Clin Nutr, 2010, 29(4): 424-433. doi: 10.1016/j.clnu.2010.02.005
[17]	张琴, 刘健. 慢性肾脏病患者蛋白质能量消耗发生机制的研究进展[J]. 中华医学杂志, 2018, 98(42): 3459-3461. doi: 10.3760/cma.j.issn.0376-2491.2018.42.017
[18]	KOMABA H, FUKAGAWA M. Secondary hyperparathyroidism and protein-energy wasting in end-stage renal disease[J]. Ther Apher Dial, 2018, 22(3): 246-250. doi: 10.1111/1744-9987.12683
[19]	MAO S, FANG L, LIU F, et al. Leptin and chronic kidney diseases[J]. J Recept Signal Transduct Res, 2018, 38(2): 89-94. doi: 10.1080/10799893.2018.1431278
[20]	袁静, 刘姣姣, 杨毅, 等. 血液透析和腹膜透析患者蛋白质能量消耗危险因素分析[J]. 中国实用内科杂志, 2020, 40(1): 45-49. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202001010.htm
[21]	PÉREZ-TORRES A, GONZÁLEZ GARCIA M E, San José-Valiente B, et al. Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics[J]. Nefrologia, 2018, 38(2): 141-151. doi: 10.1016/j.nefro.2017.06.004
[22]	HYUN Y Y, LEE K B, OH K H, et al. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease[J]. Nutrition, 2017, 33: 254-260. doi: 10.1016/j.nut.2016.06.014
[23]	吴芳, 王福诩, 周红卫. 维持性血液透析患者蛋白质能量消耗临床研究进展[J]. 中国血液净化, 2019, 18(2): 127-130. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJH201902015.htm
[24]	IKIZLER T A, BURROWES J D, BYHAM-GRAY L D, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update[J]. Am J Kidney Dis, 2020, 76(3 Suppl 1): S1-S107. http://www.sciencedirect.com/science/article/pii/S0272638620307265
[25]	GONZÁLEZ-ORTIZ A, XU H, AVESANI C M, et al. Plant-based diets, insulin sensitivity and inflammation in elderly men with chronic kidney disease[J]. J Nephrol, 2020, 33(5): 1091-1101. doi: 10.1007/s40620-020-00765-6
[26]	VERZOLA D, PICCIOTTO D, SAIO M, et al. Low protein diets and plant-based low protein diets: do they meet protein requirements of patients with chronic kidney disease[J]. Nutrients, 2020, 13(1): E83. doi: 10.3390/nu13010083
[27]	CARRERO J J, GONZÁLEZ-ORTIZ A, AVESANI C M, et al. Plant-based diets to manage the risks and complications of chronic kidney disease[J]. Nat Rev Nephrol, 2020, 16(9): 525-542. doi: 10.1038/s41581-020-0297-2
[28]	优质蛋白十佳食物排行榜[J]. 江苏卫生保健, 2020, 22(8): 48-49.
[29]	LEW Q L J, JAFAR T H, KOH H W L, et al. Red meat intake and risk of ESRD[J]. J Am Soc Nephrol, 2017, 28(1): 304-312. doi: 10.1681/ASN.2016030248
[30]	KALANTAR-ZADEH K, UPPOT R N, LEWANDROWSKI K B. Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion[J]. N Engl J Med, 2013, 369(4): 374-382. doi: 10.1056/NEJMcpc1208154
[31]	ADAMCZAK M, MASAJTIS-ZAGAJEWSKA A, MAZANOWSKA O, et al. Diagnosis and treatment of metabolic acidosis in patients with chronic kidney disease-position statement of the working group of the Polish society of nephrology[J]. Kidney Blood Press Res, 2018, 43(3): 959-969. doi: 10.1159/000490475
[32]	ADROGUÉ H J, MADIAS N E. Veverimer: an emerging potential treatment option for managing the metabolic acidosis of CKD[J]. Am J Kidney Dis, 2020, 76(6): 861-867. doi: 10.1053/j.ajkd.2020.07.019
[33]	CHAUVEAU P, APARICIO M, BELLIZZI V, et al. Mediterranean diet as the diet of choice for patients with chronic kidney disease[J]. Nephrol Dial Transplant, 2018, 33(5): 725-735. doi: 10.1093/ndt/gfx085
[34]	臧丽, 王少清. 慢性肾脏病患者运动康复管理策略研究进展[J]. 中国全科医学, 2020, 23(1): 109-113. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202001025.htm
[35]	CHEEMA B S, CHAN D, FAHEY P, et al. Effect of progressive resistance training on measures of skeletal muscle hypertrophy, muscular strength and health-related quality of life in patients with chronic kidney disease: a systematic review and meta-analysis[J]. Sports Med, 2014, 44(8): 1125-1138. doi: 10.1007/s40279-014-0176-8
[36]	梁丰, 霍文璟, 欧阳刚, 等. 不同运动方式训练对慢性肾脏病患者运动功能的影响[J]. 中国康复理论与实践, 2018, 24(2): 208-213. doi: 10.3969/j.issn.1006-9771.2018.02.017
[37]	MACHOWSKA A, CARRERO J J, LINDHOLM B, et al. Therapeutics targeting persistent inflammation in chronic kidney disease[J]. Transl Res, 2016, 167(1): 204-213. doi: 10.1016/j.trsl.2015.06.012
[38]	ABE M, MARUYAMA N, MARUYAMA T, et al. A trial of pitavastatin versus rosuvastatin for dyslipidemia in chronic kidney disease[J]. J Atheroscler Thromb, 2015, 22(12): 1235-1247. doi: 10.5551/jat.29264
[39]	吴朦朦, 吴红赤. 慢性肾脏病患者蛋白质能量消耗病因及诊治研究进展[J]. 中华实用诊断与治疗杂志, 2017, 31(5): 514-517. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201705030.htm
[40]	CARVALHO J T G, SCHNEIDER M, CUPPARI L, et al. Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: a randomized controlled pilot trial[J]. PLoS One, 2017, 12(6): e0179540. doi: 10.1371/journal.pone.0179540
[41]	易建伟, 何志红, 袁峰. 阿司匹林肠溶片对维持性血液透析患者炎症因子的影响[J]. 江西医药, 2018, 53(7): 722-724. doi: 10.3969/j.issn.1006-2238.2018.7.026
[42]	ZHENG Z G, CHEN J G, HE D Y, et al. The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients[J]. Int Urol Nephrol, 2019, 51(9): 1631-1638. doi: 10.1007/s11255-019-02245-8
[43]	KADKHODA MEZERJI F, MOHARRERI F, MOHAMMADPOUR A H, et al. Preventive effect of cyproheptadine on sleep and appetite disorders induced by methylphenidate: an exploratory randomised, double-blinded, placebo-controlled clinical trial[J]. Int J Psychiatry Clin Pract, 2019, 23(1): 72-79. doi: 10.1080/13651501.2018.1509095
[44]	MORIN V, HOZER F, COSTEMALE-LACOSTE J F. The effects of ghrelin on sleep, appetite, and memory, and its possible role in depression: a review of the literature[J]. Encephale, 2018, 44(3): 256-263. doi: 10.1016/j.encep.2017.10.012
[45]	陈爽, 吴静, 达静静, 等. 益生菌对56例腹膜透析患者蛋白质-能量消耗和微炎症状态的作用研究[J]. 中国实用内科杂志, 2019, 39(3): 260-264. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201903014.htm

[1]	LIU Xiaowei, PAN Juan, LI Jing, LI Hui. Relationships of serum tumor necrosis factor-α and glycated hemoglobin levels with painful diabetic neuropathy[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 50-54. DOI: 10.7619/jcmp.20246275
[2]	TAO Na, XU Lijun, HUANG Qi, SUN Meiyuan, YANG Xu, ZHANG Yanrong, LIU Xiaomei. Effect of out-of-hospital therapy and monitoring plans on glycosylated hemoglobin in children with newly diagnosed type 1 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 70-74. DOI: 10.7619/jcmp.20230741
[3]	ZHU Qian, SONG Yan, CHEN Jun. Predictive model of gestational diabetes mellitus based on glycated hemoglobin, glycated albumin and fasting blood glucose[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 29-34. DOI: 10.7619/jcmp.20215123
[4]	SUN Qingqing, DAI Zhiqin, WU Qian. Effect of chronic disease management strategy on controlling of glycosylated hemoglobin in patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 108-110. DOI: 10.7619/jcmp.201924034
[5]	WEI Jianqiang, NIU Huaiying. Significance of coagulation function and glycosylated hemoglobin in judging the progression of diabetes[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 61-63. DOI: 10.7619/jcmp.201922021
[6]	GONG Yi, YAN Xiaohong. Effect of pioglitazone on fasting blood glucose, postprandial 2 h blood sugar and glycated hemoglobintype in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2018, (5): 32-35. DOI: 10.7619/jcmp.201805010
[7]	KANG Jianzhong. Application of community standardized management in control of glycosylated hemoglobin and complications in patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2018, (1): 139-142. DOI: 10.7619/jcmp.201801044
[8]	ZHANG Qingchuan, ZHANG Linhua, WANG Huiqing, MA Xianqun. The changes of serum fasting blood glucose, 2 h postprandial blood glucose and HbA1c levels of patients with gestational diabetes and their relationship with adverse pregnancy outcomes[J]. Journal of Clinical Medicine in Practice, 2017, (24): 23-26. DOI: 10.7619/jcmp.201724007
[9]	ZHANG Zhongzhi, ZHANG Hongmei, ZHANG Jing. Value of 1, 5-anhydroglucitol, fructosamine and glycosylated hemoglobin in diagnosis of diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (7): 38-40. DOI: 10.7619/jcmp.201507010
[10]	LIU Fang, ZHAO Yuhua, LU Jiemin, LIU Lan. Study on relationships between insulin-like growth factor-Ⅰ in neonatal umbilical cord blood and HbAlc in the matrix with abnormal gestational glycometabolism[J]. Journal of Clinical Medicine in Practice, 2013, (13): 48-50. DOI: 10.7619/jcmp.201313016

Cited By

Get Citation

PDF

XML

Article views (396) PDF downloads (53)

Turn off MathJax

Article Contents

Abstract

References

Pathogenesis of protein energy wasting in chronic kidney disease and its prevention strategy

Abstract

References

Related Articles

Catalog

Pathogenesis of protein energy wasting in chronic kidney disease and its prevention strategy

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content